3360 SHIP HEALTHCARE HOLDINGS, INC. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3360

TSE Prime

SHIP HEALTHCARE HOLDINGS, INC.

2,554.5

JPY

-57.5

(-2.20%)

Dec 5, 1:41 pm JST

16.48

USD

Dec 4, 11:41 pm EST

Result

PTS

outside of trading hours

2,556.5

Dec 5, 1:41 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	514,353	20,505	21,287	12,172	129.0	41	May 10, 2022	J-GAAP
Mar, 2023	572,285	21,144	20,607	12,063	127.9	42	May 12, 2023	J-GAAP
Mar, 2024	630,988	24,539	25,219	13,799	146.3	50	May 10, 2024	J-GAAP
Mar, 2025	678,229	24,779	26,023	15,128	160.3	58	May 13, 2025	J-GAAP
Mar, 2026 Guidance	700,000	26,000	26,500	15,500	168.4	60	May 13, 2025	J-GAAP
YoY	+3.2%	+4.9%	+1.8%	+2.5%	+5.1%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 12, 2020	500,000	21,000	21,000	12,100	38.5	J-GAAP
Results	May 11, 2021	497,156	21,800	21,761	12,280	40	J-GAAP
Mar, 2022	May 11, 2021	Available in future release
	Mar 4, 2022
Results	May 10, 2022
Mar, 2023	May 10, 2022
Results	May 12, 2023
Mar, 2024	May 12, 2023
	Nov 10, 2023
Results	May 10, 2024
Mar, 2025	May 10, 2024
	Mar 7, 2025
Results	May 13, 2025
Mar, 2026	May 13, 2025	700,000	26,000	26,500	15,500	60	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Apr, 2001	425	-31.8	Available in future release
Mar, 2002 Changed	459	－
Mar, 2003	35,145	+7,556.9
Mar, 2004	44,045	+25.3
Mar, 2005	52,860	+20.0
Mar, 2006	62,229	+17.7
Mar, 2007	78,845	+26.7
Mar, 2008	105,871	+34.3
Mar, 2009	118,604	+12.0
Mar, 2010	140,009	+18.0
Mar, 2011	162,432	+16.0
Mar, 2012	188,839	+16.3
Mar, 2013	224,363	+18.8
Mar, 2014	259,189	+15.5
Mar, 2015	273,327	+5.5
Mar, 2016	306,853	+12.3
Mar, 2017	408,487	+33.1
Mar, 2018	425,566	+4.2
Mar, 2019	444,048	+4.3
Mar, 2020	484,395	+9.1
Mar, 2021	497,156	+2.6
Mar, 2022	514,353	+3.5
Mar, 2023	572,285	+11.3
Mar, 2024	630,988	+10.3
Mar, 2025	678,229	+7.5
Mar, 2026 Guidance	700,000	+3.2	26,000	+4.9	26,500	+1.8	168.4	+5.1

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	630,988	24,539	3.89	10.31	3.59	1.64	146.3
Mar, 2025	678,229	24,779	3.65	10.48	3.93	1.76	160.3
Mar, 2026 Guidance	700,000	26,000	3.71	10.69	4.31	1.94	168.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	678,229	24,779	26,023	15,128	160.3
Fiscal Year	Mar, 2025	Mar, 2025	Mar, 2025	Mar, 2025	Mar, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	308,765	13,173	13,109	7,920	83.9	42	May 12, 2023	J-GAAP
Oct - Mar, 2023	334,217	15,301	15,103	10,113	107.2	50	May 10, 2024	J-GAAP
Oct - Mar, 2024	368,197	17,036	17,609	9,589	101.6	58	May 13, 2025	J-GAAP
Oct - Mar, 2025 Guidance	366,615	17,821	17,778	10,068	109.4	60	Nov 11, 2025	J-GAAP
YoY	-0.4%	+4.6%	+1.0%	+5.0%	+7.7%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	21,144	7,331	14,105	-6,774	-1,022	79,020	20.69	J-GAAP
Mar, 2024	24,539	24,407	31,609	-7,202	-20,482	83,128	21.45	J-GAAP
Mar, 2025	24,779	16,359	20,384	-4,025	-24,622	74,857	19.61	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	296,771	9,238	10,116	3,686	39.1	40.1	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	310,032	7,743	8,414	5,539	58.7	32.3	Nov 8, 2024	J-GAAP
Apr - Sep, 2025	333,385	8,179	8,722	5,432	58.0	32.9	Nov 11, 2025	J-GAAP
YoY	+7.5%	+5.6%	+3.7%	-1.9%	-1.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	156,286	5,892	5,672	3,538	37.5	3.8	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	177,931	9,409	9,431	6,575	69.7	5.3	May 10, 2024	J-GAAP
Apr - Jun, 2024	155,219	3,507	4,491	3,081	32.7	2.3	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	154,813	4,236	3,923	2,458	26.1	2.7	Nov 8, 2024	J-GAAP
Oct - Dec, 2024	182,240	7,378	8,131	4,978	52.8	4.0	Feb 7, 2025	J-GAAP
Jan - Mar, 2025	185,957	9,658	9,478	4,611	48.9	5.2	May 13, 2025	J-GAAP
Apr - Jun, 2025	163,310	2,953	3,099	2,030	21.5	1.8	Aug 8, 2025	J-GAAP
Jul - Sep, 2025	170,075	5,226	5,623	3,402	36.3	3.1	Nov 11, 2025	J-GAAP
YoY	+9.9%	+23.4%	+43.3%	+38.4%	+39.4%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	128,626	+11.1	Available in future release
Jan - Mar, 2021	147,799	+16.9
Apr - Jun, 2021	114,215	+8.3
Jul - Sep, 2021	120,448	+4.5
Oct - Dec, 2021	128,491	-0.1
Jan - Mar, 2022	151,199	+2.3
Apr - Jun, 2022	121,214	+6.1
Jul - Sep, 2022	142,306	+18.1
Oct - Dec, 2022	143,600	+11.8
Jan - Mar, 2023	165,165	+9.2
Apr - Jun, 2023	146,467	+20.8
Jul - Sep, 2023	150,304	+5.6
Oct - Dec, 2023	156,286	+8.8
Jan - Mar, 2024	177,931	+7.7
Apr - Jun, 2024	155,219	+6.0
Jul - Sep, 2024	154,813	+3.0
Oct - Dec, 2024	182,240	+16.6
Jan - Mar, 2025	185,957	+4.5
Apr - Jun, 2025	163,310	+5.2
Jul - Sep, 2025	170,075	+9.9	5,226	+23.4	5,623	+43.3	36.3	+39.1

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	185,957	9,658	9,478	6,575	69.7
Fiscal Year	Mar, 2025	Mar, 2025	Mar, 2025	Mar, 2024	Mar, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	1,357.05	33.5	381,977	128,037	100,158	0.58	May 12, 2023	J-GAAP
Mar, 2024	1,478.82	36.0	387,562	139,527	109,996	0.42	May 10, 2024	J-GAAP
Mar, 2025	1,580.05	39.1	381,702	149,077	120,407	0.21	May 13, 2025	J-GAAP
Apr - Sep, 2025	ー	40.3	360,040	145,032	108,795	0.21	Nov 11, 2025	J-GAAP

SHIP HEALTHCARE HOLDINGS, INC.(3360) Financial Results